AstraZeneca PLC (AZN)
NASDAQ: AZN · Real-Time Price · USD
69.68
-0.86 (-1.22%)
At close: Jun 25, 2025, 4:00 PM
70.03
+0.35 (0.50%)
Pre-market: Jun 26, 2025, 8:34 AM EDT
AstraZeneca Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for AstraZeneca stock have an average target of 95, which predicts a 36.34% increase from the current stock price of 69.68.
Price Target: $95 (+36.34%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 12, 2024.
Analyst Ratings
The average analyst rating for AstraZeneca stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 5 | 5 | 5 | 5 | 3 |
| Buy | 2 | 1 | 1 | 1 | 1 | 0 |
| Hold | 4 | 1 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 7 | 7 | 7 | 7 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Feb 13, 2025 |
| UBS | UBS | Strong Sell → Hold Upgrades n/a | Strong Sell → Hold | Upgrades | n/a | n/a | Nov 20, 2024 |
| Erste Group | Erste Group | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Sep 11, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $90 → $95 | Strong Buy | Maintains | $90 → $95 | +36.34% | Aug 12, 2024 |
| Argus Research | Argus Research | Strong Buy Maintains $80 → $85 | Strong Buy | Maintains | $80 → $85 | +21.99% | May 30, 2024 |
Financial Forecast
Revenue This Year
59.24B
from 54.07B
Increased by 9.56%
Revenue Next Year
62.85B
from 59.24B
Increased by 6.09%
EPS This Year
4.62
from 4.50
Increased by 2.61%
EPS Next Year
5.24
from 4.62
Increased by 13.40%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 62.5B | 68.5B | 75.0B | ||
| Avg | 59.2B | 62.8B | 66.5B | ||
| Low | 52.7B | 55.7B | 57.9B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 15.5% | 15.6% | 19.4% | ||
| Avg | 9.6% | 6.1% | 5.8% | ||
| Low | -2.5% | -5.9% | -7.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 5.18 | 6.15 | 7.03 | ||
| Avg | 4.62 | 5.24 | 5.75 | ||
| Low | 3.74 | 4.35 | 4.66 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 15.0% | 33.1% | 34.3% | ||
| Avg | 2.6% | 13.4% | 9.8% | ||
| Low | -16.9% | -5.9% | -10.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.